The FDA’s fourth BE approach! [Regulatives / Guidelines]

posted by nobody – 2015-09-22 15:06 (3427 d 16:21 ago) – Posting: # 15442
Views: 17,129

...nice question for statistics exam:

Please elucidate the scientific background for the "upper limit of the 90% confidence interval for the test-to-reference ratio of the within-subject variability should be ≤ 2.5" of FDA dabigatran BE guidance

:-D

Just kidding!

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,665 registered users;
149 visitors (0 registered, 149 guests [including 9 identified bots]).
Forum time: 06:27 CET (Europe/Vienna)

There are sadistic scientists who hurry to hunt down errors
instead of establishing the truth.    Marie Curie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5